After 12 months of saffron extract oral therapy, the serum levels of MMP-9 in MS patients decreased considerably (p = 0.006), although the changes were not significant before and after 12 months of therapy compared to placebo. The gene discussed is MMP9; the disease is myeloid sarcoma.